[1]
2023. Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient Response From the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s252. DOI:https://doi.org/10.25251/skin.7.supp.252.